IGSBvsXBI
iShares 1-5 Year Investment Grade Corporate Bond ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IGSB | XBI | |
|---|---|---|
| Expense ratio | 0.040% | 0.35% |
| Assets | $23.4B | $10.4B |
| Net flow, 1 month | +$296M | −$690M |
| Net flow, 1 year | +$2.7B | +$1.1B |
| Return, YTD | -3.3% | +26.7% |
| Return, 1 year | -3.4% | +52.4% |
| Avg daily volume | 4.9M | 8.6M |
| Holdings | 3892 | 135 |
| Listed | Jan 5, 2007 | Jan 31, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS